ImmunoPrecise Antibodies ... (IPA)

AI Score

Unlock

0.44

0.01 (3.04%)

At close: Apr 17, 2025, 3:59 PM

Dividends

No dividend history available for ImmunoPrecise Antibodies Ltd..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

IPA News

6 days ago · ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods - businesswire.com
2 weeks ago · ImmunoPrecise Antibodies (IPA) Upgraded to Buy: What Does It Mean for the Stock? - zacks.com
3 weeks ago · ImmunoPrecise Antibodies Ltd. (IPA) Q3 2025 Earnings Call Transcript - seekingalpha.com
2 weeks ago · ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Misses Revenue Estimates - zacks.com
2 weeks ago · ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 - businesswire.com
1 month ago · ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics. - businesswire.com
1 month ago · IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025 - businesswire.com
1 month ago · IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 13, 2025 - businesswire.com
1 month ago · ImmunoPrecise Antibodies Announces Key Leadership Changes - businesswire.com
1 month ago · ImmunoPrecise Antibodies Announces Transfer to Nasdaq Capital Market and Extension of Bid Price Compliance Period - businesswire.com